RAYLAB SRL
Desconocido
NECTAR: NEutron Capture enhanced Treatment of neurotoxic Amyloid aggRegates
RAYLAB SRL
participó en un
H2020:
H2020-FETOPEN-2018-2020
NECTAR proposes an alternative and revolutionary strategy to address AD (Alzheimer’s Disease) treatment, suggesting and investigating a ther...
2021-01-20 - 2024-09-30 | Financiado
2021-01-20 - 2024-09-30 | Financiado
* No se disponen de datos de la empresa actual.